In fiscal year 2023, GlaxoSmithKline Pharmaceuticals Limited in India reported nearly eight billion Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's 7.5 billion rupees worth EBITDA. In financial year 2023, GSK ranked as the leading brand in the anti-infectives and dermatology segment.
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India
Market overview
6
- Premium Statistic Revenue of the OTC pharmaceuticals in selected countries worldwide
- Basic Statistic Top pharma companies worldwide by number of originated drugs 2023
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Share of pharmacy in organized retail India FY 2020-2022
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
GSK India - key figures
6
- Premium Statistic GSK's revenue by region 2013-2023
- Premium Statistic GSK's number of employees by region 2011-2023
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
- Premium Statistic GSK Pharmaceuticals' operation revenue in India FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
Product portfolio
3
Main competitiors
4
Further related statistics
17
- GSK Pharmaceuticals' CSR expenditure in India 2020 by project
- GSK Pharmaceuticals' CSR expenditure in India 2020 by type
- GSK Pharmaceuticals' market price of shares at NSE India FY 2023, by month
- GSK Pharmaceuticals' earnings per share in India FY 2015-2023
- GSK Pharmaceuticals' book value per share India FY 2015-2023
- GSK Pharmaceuticals' shareholder distribution India FY 2023
- GSK Pharmaceuticals' number of employees in India FY 2016-2023
- GSK Pharmaceuticals' remuneration of executive directors in India 2023
- GSK: expenditure on research and development 2006-2023
- GlaxoSmithKline's expenditure on research and development by sector 2015-2021
- GSK: cash flow 2006-2023
- GSK's number of employees by region 2011-2023
- GSK's profit 2006-2023
- GSK Pharmaceuticals' CSR expenditure in India 2021 by project
- Number of global oncology clinical trial starts 2012-2018, by biomarkers tested
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Number of employees at Tong Ren Tang China 2022
Further Content: You might find this interesting as well
Statistics
- GSK Pharmaceuticals' CSR expenditure in India 2020 by project
- GSK Pharmaceuticals' CSR expenditure in India 2020 by type
- GSK Pharmaceuticals' market price of shares at NSE India FY 2023, by month
- GSK Pharmaceuticals' earnings per share in India FY 2015-2023
- GSK Pharmaceuticals' book value per share India FY 2015-2023
- GSK Pharmaceuticals' shareholder distribution India FY 2023
- GSK Pharmaceuticals' number of employees in India FY 2016-2023
- GSK Pharmaceuticals' remuneration of executive directors in India 2023
- GSK: expenditure on research and development 2006-2023
- GlaxoSmithKline's expenditure on research and development by sector 2015-2021
- GSK: cash flow 2006-2023
- GSK's number of employees by region 2011-2023
- GSK's profit 2006-2023
- GSK Pharmaceuticals' CSR expenditure in India 2021 by project
- Number of global oncology clinical trial starts 2012-2018, by biomarkers tested
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Number of employees at Tong Ren Tang China 2022
GlaxoSmithKline. (June 17, 2023). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees) [Graph]. In Statista. Retrieved April 19, 2024, from https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees)." Chart. June 17, 2023. Statista. Accessed April 19, 2024. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. (2023). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees). Statista. Statista Inc.. Accessed: April 19, 2024. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "Ebitda of Gsk Pharmaceuticals Limited in India from Financial Year 2015 to 2023 (in Billion Indian Rupees)." Statista, Statista Inc., 17 Jun 2023, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline, EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees) Statista, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/ (last visited April 19, 2024)
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees) [Graph], GlaxoSmithKline, June 17, 2023. [Online]. Available: https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/